Satsuma Pharmaceuticals, Inc. Gains 63.69%

Mon, Apr 17, 2023 at 07:04 PM
Satsuma Pharmaceuticals, Inc. Gains 63.69%

Satsuma Pharmaceuticals, Inc. (STSA:NASDAQ) soared at $1.08, a gain of 63.7%. On Mon, Apr 17, 2023, STSA:NASDAQ touched a New 2-Week High of $1.08. The stock appeared on our News Catalysts scanner on Sun, Apr 16, 2023 at 08:00 PM in the 'ACQUISITION' category. From Mon, Apr 03, 2023, the stock recorded 33.33% Up Days and 20.00% Green Days

The stock spiked on Mon, Apr 17, 2023 at $1.47 with a volume of 43M+.

About Satsuma Pharmaceuticals, Inc. (STSA:NASDAQ)

Satsuma Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-administered with a pre-filled, single-use, nasal delivery device.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.